Observational study / 2016
In chronic kidney disease patients, higher TMAO levels were associated with systemic inflammation, reduced renal function, and increased all-cause mortality.
Researchers measured fasting plasma metabolites, including TMAO, choline, and betaine, in 80 controls and 179 CKD 3-5 patients. GFR was the dominant variable affecting TMAO (beta = -0.41; p<0.001), and in 74 CKD 5 patients, renal transplantation normalized TMAO levels to controls (p<0.001), while dialysis did not. TMAO levels correlated with IL-6 (Rho = 0.42; p<0.0001), fibrinogen (Rho = 0.43; p<0.0001), and hsCRP (Rho = 0.17; p=0.022). In multivariate analysis, higher TMAO was linked to increased all-cause mortality (HR 4.32, 95% CI 1.32-14.2; p=0.016).
Shows an association, not proof of cause and effect.
- Study type
- Cross-sectional and longitudinal observational study
- Who was studied
- 80 controls and 179 chronic kidney disease (CKD) stages 3-5 patients (including a longitudinal cohort of 74 CKD 5 patients)
- What was measured
- Glomerular filtration rate, inflammatory biomarkers, effects of dialysis and renal transplantation, and all-cause mortality
THE PAPER
Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C, Hällqvist J, Qureshi AR, Barany P, Heimbürger O, Lindholm B, Stenvinkel P, Bergman P. PLoS One, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.